Xenon Pharmaceuticals (XENE) Receivables - Net (2013 - 2025)
Xenon Pharmaceuticals (XENE) recorded Receivables - Net of $8.65 million in Q1 2025, up 938.3% from $833,000 a year earlier and up 488.8% from the prior quarter.
Powered by 
Analysis
Xenon Pharmaceuticals (XENE) Receivables - Net (2013 - 2025) Analysis & Trends
At the end of FY2024, Xenon Pharmaceuticals reported Receivables - Net of $1.47 million, up 68.1% from FY2023.
- Annual Receivables - Net has a five-year compound annual growth rate of 12.6% (FY2019 to FY2024).
- Across earlier years, Receivables - Net came in at $874,000 in FY2023 (-11.4%), $986,000 in FY2022 (-64.3%), $2.77 million in FY2021 (+51.8%) and $1.82 million in FY2020 (+124.1%).
- The Q1 2025 figure is the highest quarterly Receivables - Net in data going back to Q4 2013.
- On a year-over-year basis, Receivables - Net has increased for three consecutive quarters, with growth averaging 100.7% over the last eight quarters.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 944.4% in Q2 2020, against a decline of 67.6% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.47 million (Q4 2024), $938,000 (Q3 2024) and $853,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.12 Bn | 1,134.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.67 Bn | 553.20 Bn | 17.26 Bn |
| 3 | AbbVie | 503.03 Bn | 476.14 Bn | 12.70 Bn |
| 4 | Merck | 377.66 Bn | 332.04 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.82 Bn | 267.81 Bn | 11.24 Bn |
| 6 | Astrazeneca | 266.80 Bn | 240.49 Bn | 12.86 Bn |
| 7 | Amgen | 240.87 Bn | 196.27 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.45 Bn | 167.65 Bn | 6.22 Bn |
| 9 | Pfizer | 172.20 Bn | 118.84 Bn | 10.94 Bn |
| 10 | Xenon Pharmaceuticals | 3.62 Bn | 583.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 8.65 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 938,000.00 |
| Jun 30, 2024 | 853,000.00 |
| Mar 31, 2024 | 833,000.00 |
| Dec 31, 2023 | 874,000.00 |
| Sep 30, 2023 | 805,000.00 |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 986,000.00 |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 2.92 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Sep 30, 2021 | 3.24 Mn |
| Jun 30, 2021 | 2.92 Mn |
| Mar 31, 2021 | 5.06 Mn |
| Dec 31, 2020 | 1.82 Mn |
| Sep 30, 2020 | 1.61 Mn |
| Jun 30, 2020 | 1.79 Mn |
API Access
Xenon Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=XENE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "XENE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=XENE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();